Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A H J Thiadens

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Immunology (Orlando, Fla.)|January 30, 2023
Long-term data on efficacy and safety of adalimumab in Behçet's diseaseT B van der Houwen, B Humer, T O Missotten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Coronary artery fistulasS A M Said, A A H J Thiadens, M J C H Fieren, et al.
BMC Ophthalmology|November 24, 2024
Acute retinal pigment epitheliitis using adaptive optics imaging: a case reportP A T Heutinck, S Wooning, K Liman, et al.
BMC Immunology|July 3, 2025
Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort studyW H A van Poecke, N E F Hooi, T K Mossel, et al.
Frontiers in Medicine|August 28, 2020
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade<sup>®</sup> to Remsima<sup>®</sup>? An Observational StudyLaixi Xue, K van Bilsen, M W J Schreurs, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Immunology (Orlando, Fla.)|January 30, 2023
Long-term data on efficacy and safety of adalimumab in Behçet's diseaseT B van der Houwen, B Humer, T O Missotten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Coronary artery fistulasS A M Said, A A H J Thiadens, M J C H Fieren, et al.
BMC Ophthalmology|November 24, 2024
Acute retinal pigment epitheliitis using adaptive optics imaging: a case reportP A T Heutinck, S Wooning, K Liman, et al.
BMC Immunology|July 3, 2025
Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort studyW H A van Poecke, N E F Hooi, T K Mossel, et al.
Frontiers in Medicine|August 28, 2020
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade<sup>®</sup> to Remsima<sup>®</sup>? An Observational StudyLaixi Xue, K van Bilsen, M W J Schreurs, et al.
Pageof 1